NCT04552964CompletedNot Applicable
Assessment of the Impact of an add-on and Its Smartphone Application on the Daily Management of Glaucoma
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Laboratoires Thea
- Enrollment
- 31
- Locations
- 2
- Primary Endpoint
- Global patient satisfaction
Study Overview
Brief Summary
Glaucoma is one of the most common chronic pathologies and affects several millions patients. Among these, many have a poorly controlled glaucoma, damaging vision and leading to blindness.
One between principal reasons for poor glaucoma medication adherence is forgetfulness. To improve this issue, digital tools may benefit both ophthalmologists and patients by monitoring eye drop administration.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Other
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Patient > 18 years old, both genders
- •Diagnosed with glaucoma, with controlled IOP (<18mmHg)
- •Currently receiving a topical glaucoma treatment
- •Receiving a multitherapy a fixed combination of dorzolamide-timolol, preservative-free.
- •Patient willing to participate in the study.
- •Patient familiar with a smartphone and its applications
Exclusion Criteria
- •Patient with any eye condition in addition to glaucoma requiring expected additional treatment
- •Patient with an ongoing or known history of ocular allergy and/or uveitis and/or viral infection and or ocular infection.
- •Patient who underwent intraocular surgery within the past 3 months or scheduled to undergo intraocular surgery within the next 3 months
- •Patient with best-correct visual acuity <20/70 in the better seeing eye
- •Patient whose drop administration is performed by someone else
- •Alcohol addiction and/or heavy smoker, according to the investigator's judgement.
- •Patient inability to understand the study procedures or to give informed consent.
- •Non-compliant patient (e.g., not willing to attend a visit; way of life interfering with compliance).
- •Participation in this study at the same time as in another clinical study.
- •Patient being institutionalized because of legal or regulatory order, inmate of psychiatric wards, prison or state institutions, or employee of the study sites or of the sponsor's company.
- •Patient not covered by the government health care scheme of the country in which he/she is living (if applicable).
- •Women of childbearing potential, pregnant or breastfeeding: Childbearing potential is defined as a woman who is not using a reliable method of contraception (oral contraceptive, intrauterine device, subcutaneous contraceptive implant, vaginal ring, patch) or is not surgically sterilized.
Outcomes
Primary Outcomes
Global patient satisfaction
Time Frame: Week 9
Global patient satisfaction (Patient satisfaction questionnaire)
Secondary Outcomes
No secondary outcomes reported
Investigators
Study Sites (2)
Loading locations...
Similar Trials
Recruiting
Not Applicable
Matching Glaucoma With Impaired CognitionMorbidity of Primary Open Angle GlaucomaNCT03695224Sun Yat-sen University3,000
Active, not recruiting
Phase 4
A Study to Evaluate Adverse Events and Change in Disease Activity With the XEN45 Glaucoma Treatment System Implantation In Adult Participants With Open-Angle Glaucoma in ChinaOpen-angle GlaucomaOAGNCT05821855AbbVie120
Unknown
Not Applicable
Study on Micro-invasive Glaucoma Surgical (MIGS) DevicesGlaucomaNCT04092400National University Hospital, Singapore500
Completed
Phase 2
Does Adding Bevacizumab Therapy in Glaucoma Surgery Improve the Success of Needle Bleb Revisions?GlaucomaNCT00853073Wills Eye63
Completed
Not Applicable
Influence of therapeutic agent for glaucoma on biological clockJPRN-jRCTs071180026Yoshihara Tatsuya16